Monday 10 December 2018 ,
Latest News
  • Bangladesh beat West Indies by five wickets
  • Political parties can start election campaign Monday
  • 29 JaPa candidates to contest polls under Grand Alliance; 143 independently
  • Khaleda files writ to get back candidacy
  • HC asks EC to accept 5 BNP aspirants’ nominations
6 January, 2018 01:02:39 PM

Print

Common birth control drug ups risk of HIV

Independent Online/AFPAsian News International
Common birth control drug ups risk of HIV

Women beware! A study has recently warned that a popular injectable contraceptive drug can increase the risk of HIV infection in women by 40 percent.

Depot-medroxyprogesterone acetate (DMPA) is an injectable birth control shot administered every three months, which prevents the ovaries from releasing eggs and thickens the mucous layer around the cervix to block sperm from getting through.

According to researchers, transitioning away from DMPA could help protect women from becoming infected with HIV.

Human studies suggest DMPA use may raise the risk of HIV infection by 40 percent.

The findings suggest other forms of birth control should rapidly replace DMPA shots, the researchers noted.

The team wanted to review the underlying biological mechanisms that could contribute to increased risk of HIV infection for certain hormonal contraceptives but not others.

"To protect individual and public health, it is important to ensure women in areas with high rates of HIV infection have access to affordable contraceptive options," said first study author Janet P. Hapgood from the University of Cape Town in South Africa.

"Increasing availability of contraceptives that use a different form of the female hormone progestin than the one found in DMPA could help reduce the risk of HIV transmission," Hapgood added.

The team examined animal, cell and biochemical research on the form of progestin used in DMPA - medroxprogesterone acetate, or MPA.

MPA is used in birth control and as part of menopausal hormone therapy.

The analysis revealed MPA acts differently than other forms of progestin used in contraceptives.

MPA behaves like the stress hormone cortisol in the cells of the genital tract that can come in contact with HIV.

The researchers explained that the increased rate of HIV infection among women using DMPA contraceptive shots is likely due to multiple reasons, including decreases in immune function and the protective barrier function of the female genital tract.

"Studying the biology of MPA helps us understand what may be driving the increased rate of HIV infection seen in human research.

The research appears in journal of Endocrine Reviews. 

NS
 

.

Comments

Poll
Today's Question »
JP (Ershad) will contest JS polls in 29 seats under grand alliance and field 143 candidates separately under party banner. Will the decision be the decider?
 Yes
 No
 No Comment
Yes 11.1%
No 77.8%
No Comment 11.1%
Video
More Health Stories

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting